Halozyme Therapeutics Analyst Ratings
BenzingaApr 30 18:34
Halozyme Therapeutics Analyst Ratings
BenzingaApr 17 23:39
Halozyme Therapeutics Analyst Ratings
BenzingaApr 16 21:25
TD Cowen Reaffirms Their Buy Rating on Halozyme (HALO)
TipRanksMar 8 20:26
TD Cowen Initiates Coverage On Halozyme Therapeutics With Outperform Rating, Announces Price Target of $54
BenzingaFeb 29 19:59
Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), Halozyme (HALO) and Eli Lilly & Co (LLY)
TipRanksFeb 26 20:30
Halozyme Therapeutics Analyst Ratings
BenzingaFeb 21 19:44
Halozyme Therapeutics Analyst Ratings
BenzingaJan 20 00:51
JMP Securities Reiterates Market Outperform on Halozyme Therapeutics, Maintains $72 Price Target
BenzingaJan 19 00:39
Halozyme Therapeutics Analyst Ratings
BenzingaJan 18 19:17
Morgan Stanley Maintains Overweight on Halozyme Therapeutics, Lowers Price Target to $59
BenzingaDec 26, 2023 23:46
Halozyme Therapeutics Analyst Ratings
BenzingaDec 26, 2023 23:45
Benchmark Reiterates Buy on Halozyme Therapeutics, Maintains $50 Price Target
BenzingaOct 20, 2023 22:28
Halozyme Therapeutics Analyst Ratings
BenzingaOct 20, 2023 22:26
Halozyme (HALO) Gets a Buy From Wells Fargo
TipRanksOct 20, 2023 16:47
HC Wainwright & Co. Maintains Buy on Halozyme Therapeutics, Raises Price Target to $61
BenzingaOct 19, 2023 18:54
Halozyme Therapeutics Analyst Ratings
BenzingaOct 19, 2023 18:51
HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $60 Price Target
BenzingaOct 9, 2023 18:17
Halozyme Therapeutics Analyst Ratings
BenzingaOct 9, 2023 18:15
HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $60 Price Target
BenzingaSep 8, 2023 19:06
No Data
No Data